Achim Franzen1, Anja Lieder2, Thomas Guenzel3, Andre Buchali4. 1. Department of Otorhinolaryngology, Head and Neck Surgery, Brandenburg Medical University-Theodor Fontane, Campus Ruppiner Kliniken, Neuruppin, Germany a.franzen@ruppiner-kliniken.de. 2. Department of Otorhinolaryngology, Head and Neck Surgery, Brandenburg Medical University-Theodor Fontane, Campus Ruppiner Kliniken, Neuruppin, Germany. 3. ENT Practice Leer, Leer, Germany. 4. Department of Radio-Oncology and Radiotherapy, Brandenburg Medical University-Theodor Fontane, Campus Ruppiner Kliniken, Neuruppin, Germany.
Abstract
BACKGROUND/AIM: The aim of this study was to critically evaluate diagnostic workup, treatment and outcome of parotid gland squamous cell carcinoma (SCC). PATIENTS AND METHODS: We retrospectively examined 844 consecutive cases of parotid surgery in a German teaching hospital between 1975 and 2017. RESULTS: A total of 748 patients had parotid surgery. A total of 118 patients (15.7%) had a malignant tumour. Of those 49 patients had SCC accounting for 6.6% of all cases, and 41.5% of all malignant tumours. SCC typically affected males (79.6%) of advanced age. A total of 86% of patients had metastatic disease; three cases were primary SCC. Most primary carcinomas were skin (n=26) or pharynx (n=10). Four cases were carcinomas of unknown primary. We performed radical parotidectomy in 47 cases, neck dissections in 42 cases and adjuvant chemo-radiotherapy in 44 cases. CONCLUSION: The majority of parotid SCC are metastases. In cases without known primary lesion and lack of infiltrative tumour growth, a carcinoma with unknown primary should be considered. Copyright
BACKGROUND/AIM: The aim of this study was to critically evaluate diagnostic workup, treatment and outcome of parotid gland squamous cell carcinoma (SCC). PATIENTS AND METHODS: We retrospectively examined 844 consecutive cases of parotid surgery in a German teaching hospital between 1975 and 2017. RESULTS: A total of 748 patients had parotid surgery. A total of 118 patients (15.7%) had a malignant tumour. Of those 49 patients had SCC accounting for 6.6% of all cases, and 41.5% of all malignant tumours. SCC typically affected males (79.6%) of advanced age. A total of 86% of patients had metastatic disease; three cases were primary SCC. Most primary carcinomas were skin (n=26) or pharynx (n=10). Four cases were carcinomas of unknown primary. We performed radical parotidectomy in 47 cases, neck dissections in 42 cases and adjuvant chemo-radiotherapy in 44 cases. CONCLUSION: The majority of parotid SCC are metastases. In cases without known primary lesion and lack of infiltrative tumour growth, a carcinoma with unknown primary should be considered. Copyright
Authors: Tom J Vauterin; Michael J Veness; Garry J Morgan; Michael G Poulsen; Christopher J O'Brien Journal: Head Neck Date: 2006-09 Impact factor: 3.147
Authors: Ardalan Ebrahimi; Jonathan R Clark; Nazanin Ahmadi; Carsten E Palme; Gary J Morgan; Michael J Veness Journal: Head Neck Date: 2012-11-14 Impact factor: 3.147
Authors: Shira Fishbach; George Steinhardt; Chao Jie Zhen; Rutika Puranik; Jeremy P Segal; Nicole A Cipriani Journal: Head Neck Pathol Date: 2021-06-23